Surrozen (SRZN) Competitors $8.29 -0.06 (-0.72%) As of 07/8/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SRZN vs. OLMA, AARD, ZYBT, CMPS, IVA, LFCR, NGNE, AVTE, RNAC, and RCKTShould you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include Olema Pharmaceuticals (OLMA), Aardvark Therapeutics (AARD), Zhengye Biotechnology (ZYBT), COMPASS Pathways (CMPS), Inventiva (IVA), Lifecore Biomedical (LFCR), Neurogene (NGNE), Aerovate Therapeutics (AVTE), Cartesian Therapeutics (RNAC), and Rocket Pharmaceuticals (RCKT). These companies are all part of the "pharmaceutical products" industry. Surrozen vs. Its Competitors Olema Pharmaceuticals Aardvark Therapeutics Zhengye Biotechnology COMPASS Pathways Inventiva Lifecore Biomedical Neurogene Aerovate Therapeutics Cartesian Therapeutics Rocket Pharmaceuticals Surrozen (NASDAQ:SRZN) and Olema Pharmaceuticals (NASDAQ:OLMA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability. Do institutionals & insiders hold more shares of SRZN or OLMA? 66.6% of Surrozen shares are held by institutional investors. Comparatively, 91.8% of Olema Pharmaceuticals shares are held by institutional investors. 43.5% of Surrozen shares are held by insiders. Comparatively, 16.4% of Olema Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, SRZN or OLMA? Surrozen has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500. Comparatively, Olema Pharmaceuticals has a beta of 1.9, meaning that its stock price is 90% more volatile than the S&P 500. Does the media refer more to SRZN or OLMA? In the previous week, Olema Pharmaceuticals had 1 more articles in the media than Surrozen. MarketBeat recorded 1 mentions for Olema Pharmaceuticals and 0 mentions for Surrozen. Surrozen's average media sentiment score of 0.00 equaled Olema Pharmaceuticals'average media sentiment score. Company Overall Sentiment Surrozen Neutral Olema Pharmaceuticals Neutral Do analysts rate SRZN or OLMA? Surrozen currently has a consensus target price of $38.50, indicating a potential upside of 364.41%. Olema Pharmaceuticals has a consensus target price of $24.50, indicating a potential upside of 429.16%. Given Olema Pharmaceuticals' higher possible upside, analysts plainly believe Olema Pharmaceuticals is more favorable than Surrozen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surrozen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Olema Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SRZN or OLMA more profitable? Olema Pharmaceuticals' return on equity of -42.31% beat Surrozen's return on equity.Company Net Margins Return on Equity Return on Assets SurrozenN/A -842.90% -71.32% Olema Pharmaceuticals N/A -42.31%-38.32% Which has stronger earnings & valuation, SRZN or OLMA? Surrozen has higher revenue and earnings than Olema Pharmaceuticals. Olema Pharmaceuticals is trading at a lower price-to-earnings ratio than Surrozen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurrozen$10.65M6.66-$63.56M-$24.96-0.33Olema PharmaceuticalsN/AN/A-$129.47M-$2.01-2.30 SummaryOlema Pharmaceuticals beats Surrozen on 8 of the 12 factors compared between the two stocks. Get Surrozen News Delivered to You Automatically Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRZN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRZN vs. The Competition Export to ExcelMetricSurrozenMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$71.50M$2.39B$5.47B$8.95BDividend YieldN/A1.80%5.25%4.06%P/E Ratio-0.338.9827.0020.10Price / Sales6.66729.50435.75120.29Price / CashN/A159.8036.8257.86Price / Book-1.274.517.985.56Net Income-$63.56M$31.26M$3.16B$248.40M7 Day Performance-5.15%3.57%2.40%4.67%1 Month Performance-5.80%1.28%2.19%6.64%1 Year Performance-17.27%1.08%33.82%21.31% Surrozen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRZNSurrozen2.3444 of 5 stars$8.29-0.7%$38.50+364.4%-21.0%$71.50M$10.65M-0.3380OLMAOlema Pharmaceuticals1.7128 of 5 stars$4.36+2.3%$24.50+462.4%-58.0%$300.30MN/A-2.1870AARDAardvark TherapeuticsN/A$13.77+1.8%$33.00+139.7%N/A$298.81MN/A0.0018Gap UpZYBTZhengye BiotechnologyN/A$6.33+6.0%N/AN/A$298.59MN/A0.00278Lockup ExpirationCMPSCOMPASS Pathways2.1965 of 5 stars$3.16+12.7%$17.00+438.8%-44.6%$296.12MN/A-1.59120High Trading VolumeIVAInventiva2.753 of 5 stars$3.09-3.1%$10.40+236.5%+31.6%$295.69M$9.95M0.00100News CoverageGap UpLFCRLifecore Biomedical0.9959 of 5 stars$7.92-2.5%$8.00+1.0%+63.8%$292.54M$128.26M-5.45690Positive NewsNGNENeurogene3.6125 of 5 stars$20.43+36.6%$46.17+126.0%-44.9%$290.55M$930K-4.6890High Trading VolumeAVTEAerovate TherapeuticsN/A$9.99+8.7%N/A-82.8%$289.56MN/A-3.3420High Trading VolumeRNACCartesian Therapeutics1.4099 of 5 stars$11.09+6.7%$41.25+272.0%-32.8%$287.79M$38.91M-0.2164RCKTRocket Pharmaceuticals4.8509 of 5 stars$2.62+6.7%$18.60+611.3%-85.7%$284.60MN/A-1.01240Trending News Related Companies and Tools Related Companies OLMA Competitors AARD Competitors ZYBT Competitors CMPS Competitors IVA Competitors LFCR Competitors NGNE Competitors AVTE Competitors RNAC Competitors RCKT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRZN) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRZN Stock Alerts